Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Ensoma
75 Kneeland St., 14th Floor
Boston, MA 02111
https://ensoma.com/

Ensoma's Engenious platform has been extensively validated in numerous preclinical models with a range of genome editing technologies, demonstrating robust genetic modification of bone marrow HSCs and stable long-term expression of therapeutic proteins in small and large preclinical models.

Key Contact
Name
Kush M. Parmar
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
02/12/21 $70,000,000 Series A 5AM Ventures
Alexandria Venture Investments
Cormorant Asset Management
F-Prime Capital Partners
RIT Capital
Symbiosis
Takeda Ventures
Viking Global Investors


Featured Reading